Journal of Cancer Therapeutics and Immunotherapy

ABSTRACT

Cancer continues to be one of the leading causes of morbidity and mortality worldwide. The complications and diversity of the complaint bear the development of more effective and targeted treatment strategies. Cancer biomarkers, which include inheritable, proteomic, and epigenetic pointers, have surfaced as vital tools for early opinion, prognostic, and monitoring of remedial efficacity. individualized treatment, which knitter’s curatives grounded on individual molecular biographies, has gained significant attention in recent times. This composition discusses the significance of cancer biomarkers in the environment of individualized drug, their part in enhancing case issues, and the challenges and unborn directions of biomarker- grounded diagnostics and curatives.

Article History

Received 25 October 2024; Revised 25 November 2024; Accepted 06 December 2024

KEYWORDS

1. Cancer biomarkers
2. Molecular profiling
3. Cancer diagnosis
4. Liquid biopsy
5. Therapeutic monitoring